T1	Participants 39 111	laser and radiofrequency ablation in patients with HCC smaller than 4 cm
T2	Participants 144 287	to compare percutaneous laser ablation (PLA) and radiofrequency thermoablation (RFA) for the treatment of hepatocellular carcinoma (HCC) ≤ 4 cm
T3	Participants 345 383	Thirty patients with single HCC ≤ 4 cm
T4	Participants 445 530	15 patients were treated with PLA, using a multifibre system connected to a neodymium
T5	Participants 570 641	15 patients were treated with RFA, using an expandable needle electrode
T6	Participants 679 689	12 months.
T7	Participants 734 809	87 % lesions treated with PLA and in 93 % lesions treated with RFA (p = ns)
T8	Participants 863 898	3, 6 and 12 months were comparable.
T9	Participants 1042 1053	13 patients
T10	Participants 1162 1243	RFA is more effective in the treatment of HCC compared to PLA for lesions ≥ 21 mm
